Table 4.
Blood count values of the groups evaluated.
| NoCoV-2-Prof | CoV-2-Prof | No-Prof | P | |
|---|---|---|---|---|
| WBC (x 103/μL) | 7.62 ± 3.3 | 2.8 ± 1.41 ** | 6.41 ± 1.8 | 0.0052 |
| Rods (%) | 0.7 ± 0.72 | 0 | 0.5 ± 0.56 | 0.1292 |
| Neutrophil (%) | 68 ± 10.7 | 39.0 ± 2.12 *** | 67 ± 4.9 | 0.0001 |
| Eosinophil (%) | 2.0 ± 0.68 ** | 2 ± 1 ** | 1.0 ± 0.80 | 0.0043 |
| Basophil (%) | 0.3 ± 0.4 | 0 | 1.0 ± 0.31 | 0.9082 |
| Lymphocyte (%) | 24 ± 3.9 | 45.0 ± 3.53 *** | 26 ± 3.4 | 0.0001 |
| Monocyte (%) | 5.0 ± 1.30 | 15 ± 1.41 *** | 4.5 ± 3.1 | 0.0001 |
| RBC (x 106/μL) | 4.75 ± 0.63 ** | 3.9 ± 0.19 | 4.23 ± 0.38 | 0.0003 |
| Hb (g/dL) | 13 ± 0.81 | 10.9 ± 0.56 * | 14.2 ± 1.56 | 0.0415 |
| Ht (%) | 34.8 ± 12.9 * | 34.3 ± 1.83 * | 37.1 ± 3.3 | 0.0365 |
| MCV (fl) | 82.7 ± 13.5 ** | 85 ± 2.82 | 87.8 ± 3.8 | 0.0094 |
| MCH (pg) | 33.0 ± 12.9 | 29.3 ± 0.91 | 32.7 ± 3.4 | 0.7709 |
| MCHC (g/dL) | 33.8 ± 13.4 | 34.4 ± 1.69 | 37.6 ± 3.1 | 0.7463 |
| PLT (x 103/μL) | 311 ± 113.4 | 125 ± 21.21 * | 274.3 ± 65.9 | 0.0126 |
Data are expressed as mean ± SD of the NoCoV-2-Prof and CoV-2-Prof groups compared to the No-Prof (control). *p < 0.05; **p < 0.01; ***p < 0.001 compared to control.